On August 25, 2023, T2 Biosystems Inc (TTOO) stock had a median target price of 0.15, according to two analysts offering 12-month price forecasts. The high estimate was 0.18, while the low estimate was 0.12. This median estimate represents a significant -59.13% decrease from the last recorded price of 0.37.T2 Biosystems, Inc. Common Stock (TTOO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Sep 7, 2023 · Date. Title. 10/06/23. T2 Biosystems Reports Granting of Inducement Award. 10/05/23. T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023. 09/19/23. T2 Biosystems Receives FDA 510 (k) Clearance for the T2Biothreat Panel. 09/15/23. T2 Biosystems, Inc. TTOO shares are trading higher Monday after the FDA cleared the company's biothreat panel for commercial distribution. The Details: T2 Biosystems received the FDA 510(k) decision of substantially equivalent for its T2 Biothreat Panel, a multiplex nucleic acid detection system for biothreat agents before the market open on ...Torsten Asmus. T2 Biosystems (NASDAQ:TTOO) said its board has approved a 1-for-100 reverse stock split of its common shares, effective Oct. 12.The split-adjusted …T2 Biosystems Inc. (TTOO) experienced a significant drop in its stock performance on October 13, 2023. The stock opened at $10.47, which was much lower …Get the latest T2 Biosystems Inc (TTOO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Latest TTOO News. Get all financial information for T2 Biosystems Inc (TTOO) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week …$0.2799 $0.0171 (6.51%) Today $0.28 0.0039 (1.39%) After Hours About Feed News Sentiment Earnings Fundamentals T2 Biosystems, Inc. engages in the development of …Oct 12, 2023 · T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023. T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2023 after market close Monday, August 7, RHEA-AI. neutral. Aug 3, 2023 · In July, GSA Capital Partners acquired 799,572 shares of TTOO stock for about 11.5 cents apiece. With shares currently trading near 40 cents, that’s a pretty good short-term return. The ... Traveling can be a stressful experience, especially when you are stuck in an airport waiting for your flight. But if you’re flying out of Manchester T2, there is a great way to make your time more enjoyable and comfortable: use an airport l...Oct 12, 2023 · https://www.t2biosystems.com. T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum ... 3 analysts estimate that T2 Biosystems will report losses of $1.202 per share as opposed to losses of $5.000 per share from the same quarter last year. Wall Street is expecting the company to ...And retail investor favorite T2 Biosystems fell sharply after announcing a 1-for-100 reverse stock split as it tries to maintain compliance with the Nasdaq's minimum price requirement of $1. 😮 ... The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their ...Popular Careers with T2 Biosystems Job Seekers. Public Affairs Specialist Career. Jobs Salaries Interviews. Field Service Engineer Career. Jobs Salaries Interviews. Regional Sales Manager Career. Jobs Salaries Interviews. Research Assistant Career. Jobs Salaries Interviews. Bioinformatics Scientist Career.LEXINGTON, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards... T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase Globe Newswire • about 1 month ago LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Company’s board of directors (the “Board”) has approved a reverse stock split of its common stock at a ratio of 1 post-split share for every 100 pre-split shares. Get the latest T2 Biosystems Inc (TTOO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. T2 Biosystems. 101 Hartwell Avenue. Lexington, MA 02421. Phone: 781-457-1200. Fax: 781-357-3080. Email Us. At T2 Biosystems, our mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster.Sep 11, 2023 · T2 Biosystems will likely see a similar drawdown (at least without positive FDA news). The company is popular among retail traders, and a sudden price decrease will cause many to lose interest. 3 analysts estimate that T2 Biosystems will report losses of $1.202 per share as opposed to losses of $5.000 per share from the same quarter last year. Wall Street is expecting the company to ...July 24, 2023 - 4:05 pm. LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2023 after market close Monday, August 7, 2023.Based on 2 Wall Street analysts offering 12 month price targets for T2 Biosystems in the last 3 months. The average price target is $0.15 with a high forecast of $0.18 and a low forecast of $0.12. The average price target represents a -46.41% change from the last price of $0.28. Highest Price Target $0.18. Average Price Target $0.15.The latest messages and market ideas from MR.T2 (@YellowSunflowerT2) on Stocktwits. T2 Biosystems 💯 investor, sepsis survior. Join the Conversation! Build your trading network; ... T2 Biosystems 💯 investor, sepsis survior. Strategy: Joined 3/2023. 10 Following 226 Followers. 2,687 Posts. 841 Liked. 1 Watchlist. Portfolio.Layovers can be a stressful experience, especially when you’re stuck in an airport for hours on end. But if you’re passing through Manchester T2, there’s a way to make your layover more comfortable and enjoyable.T2 Biosystems ( NASDAQ: TTOO) is a bygone favorite of mine that has bumped along on the fringes. I last discussed it in 08/2020's "COVID-19 Opportunity Knocks, T2 Answers". At the time, T2 was ...https://www.t2biosystems.com. T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum ...T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before. T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most ... Get the latest T2 Biosystems Inc (TTOO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Traveling can be a stressful experience, especially when you are stuck in an airport waiting for your flight. But if you’re flying out of Manchester T2, there is a great way to make your time more enjoyable and comfortable: use an airport l...T2 Biosystems, Inc. (TTOO.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock T2 Biosystems, Inc. | Nasdaq: TTOO ...LEXINGTON, Mass., July 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced ...In 2014, Massachusetts-based T2 Biosystems (NASDAQ: TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion ...T2 Biosystems Inc (NASDAQ:TTOO) T2 Biosystems Inc. 0.2783. Delayed Data. As of Oct 09. +0.0155 / +5.90%. Today’s Change. 0.05. Today ||| 52-Week Range.T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most expensive conditions in hospitals today. The T2Dx Instrument and T2Candida Panel have received marketing authorization from the U.S. Food and Drug Administration. All other T2 Biosystems products are considered ... Recent Highlights. Preliminary unaudited second quarter 2022 total revenue is expected to be $5.8 to $6.1 million, including product revenue of $2.5 to $2.7 million and research revenue of $3.3 to ...TipRanksT2 Biosystems, Inc. Company has Filed an Appeal and will Present a Plan to Regain Compliance. LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the ...Track T2 Biosystems Inc (TTOO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights …LEXINGTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced ...T2 Biosystems (NASDAQ: TTOO) stock is getting a boost on Wednesday after announcing plans to investigate monkeypox tests. According to a press release from the in vitro diagnostics company, it’s ...July 12, 2023 - 8:30 am. Received record quarterly sepsis test panel orders and strengthened balance sheet. LEXINGTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial and operational results for the second quarter 2023.TTOO stock is up over 300% in the last three months, but it is down 75% in 2023. T2 Biosystems (NASDAQ: TTOO) stock is the top-trending ticker on social media, and its shares are up over 30% today ...T2 Biosystems, Inc. (NASDAQ:TTOO Get Free Report) saw unusually large options trading activity on Thursday. Stock investors acquired 4,035 call options on the company. This …Discover historical prices for TTOO stock on Yahoo Finance. View daily, weekly or monthly format back to when T2 Biosystems, Inc. stock was issued. And retail investor favorite T2 Biosystems fell sharply after announcing a 1-for-100 reverse stock split as it tries to maintain compliance with the Nasdaq’s minimum …T2 Biosystems, Inc. Company has Filed an Appeal and will Present a Plan to Regain Compliance. LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the ...101 Hartwell Avenue. Lexington, MA 02421. Phone: 781-457-1200. Fax: 781-357-3080. Email Us. BARDA Contract will advance technology for the diagnosis and treatment of bloodstream infections T2 Biosystems has been awarded a milestone-based contract from the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the ... T2 Biosystems shares are frequently volatile, due in part to out-sized interest from the retail investor community. TTOO is currently one of the top trending tickers on Yahoo! Finance and Stocktwits.Bad financials. I posted earlier this week its a 50/50 gamble for today's earnings report. Regrettably this was a loss. The CEO did not grow the company organically to a $1.00 share price. The financials are bad. Really dissapointed and I lost a lot of $$. I'll just tell myself that $$ was well spent in learning the following lesson - If your ...Get the latest Citius Pharmaceuticals Inc (CTXR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.TTOO stock is up over 300% in the last three months, but it is down 75% in 2023. T2 Biosystems (NASDAQ: TTOO) stock is the top-trending ticker on social media, and its shares are up over 30% today ...LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report preliminary financial results for the third quarter 2023 and business updates after market close on Thursday, October 12, 2023.Latest TTOO News. View. Discover T2 Biosystems Inc (TTOO) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits community.Chairman and Chief Executive Officer. John Sperzel joined T2 Biosystems as President and Chief Executive Officer, as well as a member of our Board of Directors in January 2020. Prior to that, he served as President and CEO of Chembio Diagnostics, Inc. (NASDAQ: CEMI), a leading point-of-care diagnostics company focused on infectious …In early August, I wrote about how shares of T2 Biosystems (NASDAQ:TTOO) could rise to $1 or more in a short-term frenzy. Meme investors had singled out the stock, and heavy options trading meant ...Aug 9, 2023 · In 2014, Massachusetts-based T2 Biosystems (NASDAQ:TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion industry ... T2 Biosystems Inc. $0.17. TTOO 43.87%. Inpixon. $0.10. INPX 0.30%. In the news. Yahoo Finance. 1 week ago. Tingo Group Announces Appointments of Group Chief Financial Officer, Independent Director ...Oct 12, 2023 · T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023. T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2023 after market close Monday, August 7, RHEA-AI. neutral. T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023. T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2023 after market close Monday, August 7, RHEA-AI. neutral.1 day ago · T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic ... LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report preliminary financial results for the third quarter 2023 and business updates after market close on Thursday, October 12, 2023.T2 will have its second quarter report out on Tuesday, August 11 after the bell, but already last month released its preliminary numbers -- and they look good: Estimated second quarter 2020 total revenue is expected to be in the range of $2.4 million to $2.6 million, compared to $1.8 million in the prior year period. In July, GSA Capital Partners acquired 799,572 shares of TTOO stock for about 11.5 cents apiece. With shares currently trading near 40 cents, that’s a pretty good short-term return. The ...LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial results for the first quarter ended March 31, 2023. Recent Financial and Operational Highlights. Achieved …1 Wall Street research analysts have issued 12-month price targets for T2 Biosystems' shares. Their TTOO share price forecasts range from $2.50 to $2.50. On average, they expect the company's share price to reach $2.50 in the next twelve months. This suggests a possible upside of 1,236.2% from the stock's current price.And retail investor favorite T2 Biosystems fell sharply after announcing a 1-for-100 reverse stock split as it tries to maintain compliance with the Nasdaq's minimum price requirement of $1. 😮 ... The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their ...Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -6.56M. -84.77%. Get the latest Genprex Inc (GNPX) real-time quote, historical ...The astonishing transaction involved the sale of a staggering 5,079,344 shares of T2 Biosystems, resulting in a remarkable sum of $1,314,534. While insider transactions like this one hold a certain level of significance in the realm of investment decision-making, it is crucial to consider various factors before drawing any conclusions.Aug 9, 2022 · August 9, 2022 at 5:30 AM · 5 min read. T2 Biosystems, Inc. LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing ... T2 Biosystems, Inc. (TTOO) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. As of 01:11PM EDT. Market open. Find the latest T2 Biosystems, Inc. (TTOO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Recent Highlights. Preliminary unaudited second quarter 2022 total revenue is expected to be $5.8 to $6.1 million, including product revenue of $2.5 to $2.7 million and research revenue of $3.3 to ...Company Type For Profit. Contact Email [email protected]. Phone Number +1 781 457 3920. T2 Biosystems is a private company developing a next-generation medical diagnostic platform that enables rapid and accurate diagnostic tests of all types on a single, easy-to-use instrument. The company's proprietary technology combines nanotechnology ...LEXINGTON, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted an application with the U.S. Food and Drug Administration (FDA) for Breakthrough Device Designation for the …t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease ...Die T2 Biosystems Inc Registered Shs Aktie wird unter der ISIN US89853L2034 an den Börsen Frankfurt, Düsseldorf, München, Stuttgart, Hamburg, Berlin, NASDAQ, London, Bats, NASDAQ Bsc, Gettex ... Find real-time TTOO - T2 Biosystems Inc stock quotes, company profile, news and forecasts from CNN Business. Oct 11, 2023 · T2 Biosystems GAAP EPS of -$0.08 beats by $0.19, revenue of $1.96M misses by $0.04M. See All News ». The volatility of T2 BIOSYSTEMS INC's share price is greater than that of 98.27% US stocks with at least 200 days of trading history. If you're looking for stocks that are quantitatively similar to T2 BIOSYSTEMS INC, a group of peers worth examining would be AXDX, KALA, SCKT, WISA, and OCUL. TTOO's SEC filings can be seen here.The volatility of T2 BIOSYSTEMS INC's share price is greater than that of 98.27% US stocks with a, 1 Wall Street research analysts have issued 12-month price targets for T2 Biosy, T2 Biosystems Inc (TTOO) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News 2.7, Created with Sketch. StockTwits · TradingView · Tiktok · LinkedIn &, Amount of cash a business has after it has met its financial obligations suc, T2 Biosystems shares plummeted 47% to $9.19 on forecasts of low, LEXINGTON, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a le, 1 Wall Street research analysts have issued 12-month price targ, Get the latest Allarity Therapeutics Inc (ALLR) real-time quote, his, If you’re planning a trip through Manchester T2, chances are you’ll, Chairman and Chief Executive Officer. John Sperzel join, Recent Highlights. Preliminary unaudited second quarter 2022 total, Get the latest updated list of insiders for T2 Biosys, Quote Chart Stock Analysis News Price vs Fair Valu, Jul 12, 2023 · LEXINGTON, Mass., July 12, 2023 (GLOBE NEWSW, That’s a massive surge compared to its daily average trading volume o, Amount of cash a business has after it has met its financial obli, August 9, 2022 at 5:30 AM · 5 min read. T2 Biosystems, Inc. LEXING.